ClinVar Miner

Submissions for variant NM_001614.5(ACTG1):c.81C>T (p.Pro27=)

gnomAD frequency: 0.00004  dbSNP: rs11549230
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000194929 SCV000246321 uncertain significance not specified 2015-05-26 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000194929 SCV001365478 likely benign not specified 2012-04-30 criteria provided, single submitter clinical testing Pro27Pro in Exon 02 of ACTG1: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 1/7020 European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs11549230).
GeneDx RCV001657977 SCV001881817 benign not provided 2021-01-10 criteria provided, single submitter clinical testing
Invitae RCV002054248 SCV002401425 benign Autosomal dominant nonsyndromic hearing loss 20; Baraitser-winter syndrome 2 2023-11-27 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001657977 SCV004144623 benign not provided 2022-07-01 criteria provided, single submitter clinical testing ACTG1: BS1, BS2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.